Latin American Multicenter Cardiovascular Magnetic Resonance Reference Study
1 other identifier
observational
300
1 country
1
Brief Summary
This study was designed to investigate the physiological properties of adult heart using cardiovascular magnetic resonance imaging in normal volunteers in Latin America.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Dec 2009
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 9, 2009
CompletedFirst Posted
Study publicly available on registry
December 11, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedJanuary 5, 2015
January 1, 2015
4 years
December 9, 2009
January 2, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
CMR data: end-diastolic volume, end-systolic volume, stroke volume, cardiac output, ejection fraction, mass, ascending and descending aortic diameters, aortic arch diameter, atrial diameter, interventricular septum thickness, posterior wall thickness.
At enrollment of patients (time zero). No follow-up will be performed since the trial is cross-sectional
Eligibility Criteria
Normal healthy individuals
You may qualify if:
- Asymptomatic subjects with 20 to 80 years of age with no history of cardiac disease, no known risk factors with normal physical examination and ECG
You may not qualify if:
- Current smokers or smokers with \< 10 years of quitting
- Systolic blood pressure \> 120mmHg or diastolic blood pressure \> 80mmHg
- Fasting blood glucose \> 100mg/dL
- Total cholesterol \> 240mg/dL
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Campinas
Campinas, São Paulo, 13100, Brazil
Study Officials
- PRINCIPAL INVESTIGATOR
Juliano L Fernandes, MD, PhD
University of Campinas, Brazil
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician Reasearcher
Study Record Dates
First Submitted
December 9, 2009
First Posted
December 11, 2009
Study Start
December 1, 2009
Primary Completion
December 1, 2013
Study Completion
December 1, 2013
Last Updated
January 5, 2015
Record last verified: 2015-01